Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics
Sonam Bhatia, Melissa Kramer, Suzanne Russo, et al.
Cancer Research (2022) Vol. 82, Iss. 7, pp. 1174-1192
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Roles of Notch Signaling in the Tumor Microenvironment
Antonino B. D’Assoro, Roberto A. Leon‐Ferre, Eike-Benjamin Braune, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6241-6241
Open Access | Times Cited: 48
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Françoise Derouane, Cédric van Marcke, Martine Berlière, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3876-3876
Open Access | Times Cited: 47
Tumor organoid biobank-new platform for medical research
Xuexue Xie, Xinyu Li, Wei Song
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Cancer organoids: A platform in basic and translational research
Xin Ma, Qin Wang, Guozheng Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 614-632
Open Access | Times Cited: 19
Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective
Mylena M. O. Ortiz, Eran R. Andrechek
Journal of Mammary Gland Biology and Neoplasia (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 19
Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
Xinxin Rao, Zhibin Qiao, Yang Yang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 225-225
Open Access | Times Cited: 6
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment
Rita Turpin, Ruixian Liu, Pauliina Munne, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008053-e008053
Open Access | Times Cited: 6
Patient-derived organoids: a promising tool for breast cancer research
Yixin Shi, Zhanwen Guan, Gengxi Cai, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
Olaf Klingbeil, Damianos Skopelitis, Claudia Tonelli, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2471-2488
Open Access | Times Cited: 5
Single-Cell Transcription Mapping of Murine and Human Mammary Organoids Responses to Female Hormones
Jenelys Ruiz Ortiz, Steven M. Lewis, Michael F. Ciccone, et al.
Journal of Mammary Gland Biology and Neoplasia (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Toxoflavin analog D43 exerts antiproliferative effects on breast cancer by inducing ROS-mediated apoptosis and DNA damage
Tingyue Wu, Wenjing Liu, Hui Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Triblock polymer PDMAEMA-co-PNIPAM-co-PMPC to deliver siKRAS for gene therapy in pancreatic cancer
Lidong Cao, Mengmeng Dong, Kai Jiang, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 149884-149884
Open Access | Times Cited: 4
The Transformative Role of 3D Culture Models in Triple-Negative Breast Cancer Research
Xavier S. Bittman‐Soto, Evelyn S. Thomas, Madeline Ganshert, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1859-1859
Open Access | Times Cited: 4
The latest progress of personalized drug screening and therapy research for common clinical tumors through the PDX model platform
Yuliang Yuan, Hongling Gao, Yanhong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101225-101225
Open Access
RFX5 promotes the progression of triple-negative breast cancer through transcriptional activation of JAG1
Chenhao Li, Xin Wang, Dongliang Shi, et al.
Human Cell (2025) Vol. 38, Iss. 3
Closed Access
Integration of Organoids With CRISPR Screens: A Narrative Review
Rushikesh Sunil Mukhare, Khushboo Gandhi, A. S. Kadam, et al.
Biology of the Cell (2025) Vol. 117, Iss. 4
Open Access
Pan-Cancer PDOs Preserve Tumor Heterogeneity and Uncover Therapeutic Vulnerabilities
Hui–Hsuan Kuo, Bhavneet Bhinder, Hamza N. Gokozan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Clinical applications of 3D normal and breast cancer organoids: A review of concepts and methods
Steven M. Lewis, Mackenzie K. Callaway, Camila O. dos Santos
Experimental Biology and Medicine (2022) Vol. 247, Iss. 24, pp. 2176-2183
Open Access | Times Cited: 16
Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts
Lisa Nocquet, Julie Roul, Chloé C. Lefebvre, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology (2024) Vol. 51, pp. 102226-102226
Open Access | Times Cited: 3
Biomimetic hydrogels with mesoscale collagen architecture for patient-derived tumor organoids culture
Jiaxin Wang, Zhilin Sui, Wei Huang, et al.
Bioactive Materials (2024) Vol. 38, pp. 384-398
Open Access | Times Cited: 2
The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Iason Psilopatis, Amalia Mantzari, Kleio Vrettou, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 773-773
Open Access | Times Cited: 6
Exploring tumor organoids for cancer treatment
Hairong Jin, Qian Yang, Jing Yang, et al.
APL Materials (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 2
Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma
Diogo Maia-Silva, Patrick J. Cunniff, Allison C. Schier, et al.
Nature Genetics (2024) Vol. 56, Iss. 7, pp. 1377-1385
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top